** Shares of biopharma co Immuron Ltd IMC.AX up 3.8% at
A$0.083, their highest since Nov. 16
** Co says submitted an investigational new drug application
to U.S. FDA for travelan, an oral immunotherapeutic drug for
treatment of gut-mediated diseases
** Shares mark their biggest intraday pct gain since Nov. 28
** Over 110,600 shares traded vs 30-day avg of ~98,350
** Stock down 20% this year, as of last close, vs a 1.92%
decline in the benchmark S&P/ASX 200 index .AXJO
(Reporting by Roushni Nair in Bengaluru)
((Roushni.Nair@thomsonreuters.com;))